Growth Metrics

Genmab A (GMAB) Receivables - Other: 2019-2020

Historic Receivables - Other for Genmab A (GMAB) over the last 2 years, with Dec 2020 value amounting to $11.4 million.

  • Genmab A's Receivables - Other rose 95.49% to $11.4 million in Q4 2020 from the same period last year, while for Dec 2020 it was $11.4 million, marking a year-over-year increase of 95.49%. This contributed to the annual value of $11.4 million for FY2020, which is 95.49% up from last year.
  • Latest data reveals that Genmab A reported Receivables - Other of $11.4 million as of FY2020, which was up 95.49% from $5.8 million recorded in FY2019.
  • In the past 5 years, Genmab A's Receivables - Other ranged from a high of $11.4 million in FY2020 and a low of $5.8 million during FY2019.
  • In the last 2 years, Genmab A's Receivables - Other had a median value of $8.6 million in 2020 and averaged $8.6 million.
  • Data for Genmab A's Receivables - Other shows a peak YoY skyrocketed of 95.49% (in 2020) over the last 5 years.
  • Yearly analysis of 2 years shows Genmab A's Receivables - Other stood at $5.8 million in 2019, then skyrocketed by 95.49% to $11.4 million in 2020.